MedPath

Aplisol

APLISOL (Tuberculin Purified Protein Derivative, Diluted [Stabilized Solution])

Approved
Approval ID

1e91a67c-1694-4523-9548-58f7a8871134

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 31, 2017

Manufacturers
FDA

Par Pharmaceutical, Inc.

DUNS: 092733690

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tuberculin Purified Protein Derivative

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42023-104
Application NumberBLA103782
Product Classification
M
Marketing Category
C73585
G
Generic Name
Tuberculin Purified Protein Derivative
Product Specifications
Route of AdministrationINTRADERMAL
Effective DateNovember 1, 2017
FDA Product Classification

INGREDIENTS (3)

TUBERCULIN PURIFIED PROTEIN DERIVATIVEActive
Quantity: 5 [iU] in 0.1 mL
Code: I7L8FKN87J
Classification: ACTIB
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
PHENOLInactive
Code: 339NCG44TV
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Aplisol - FDA Drug Approval Details